baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UniCredit Call 140 MRK 15.05.2024/ DE000HD4VZ38 /

2024-04-30 8:34:19 PM	Chg.-	Bid10:00:44 PM	Ask10:00:44 PM	Underlying	Strike price	Expiration date	Option type
0.980EUR	-	- Bid Size: -	- Ask Size: -	MERCK KGAA O.N.	140.00 -	2024-05-15	Call

GlobeNewswire 12:59 PM Mersana Therapeutics Provides Business Update and Announces First Quarter 2024 Financial Results

GlobeNewswire 05-08 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 05-08 Coherus Announces Clinical Collaboration with the Cancer Research Institute for a Novel Combination ...

GlobeNewswire 05-08 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...

GlobeNewswire 05-08 Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...

GlobeNewswire 05-07 CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...

GlobeNewswire 05-06 Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...

GlobeNewswire 05-02 Cerevance Achieves First Milestone in Research Collaboration with Merck

TeleTrader 04-25 Merck's Q1 sales rise by 9% to $15.8 billion

GlobeNewswire 04-02 Vaccinex Reports 2023 Financial Results and Provides Corporate Update

GlobeNewswire 03-04 C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...

TeleTrader 02-02 Merck Group to expand investment in South Korea

TeleTrader 02-01 Merck's Q4 sales up 6% to $14.6B

TeleTrader 01-27 J&J, Merck CEOs to testify before Senate on drug prices

GlobeNewswire 01-23 Unnatural Products, Inc. Enters Research Collaboration with Merck

GlobeNewswire 2023-12-21 Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...

GlobeNewswire 2023-12-14 ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...

TeleTrader 2023-10-26 Merck's Q3 sales up 7% to $16B

TeleTrader 2023-10-20 Daiichi Sankyo, Merck announce collaboration on cancer drugs

GlobeNewswire 2023-10-17 ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA

GlobeNewswire 2023-09-28 Merck KGaA, Darmstadt, Germany and Quris-AI Expand Collaboration

TeleTrader 2023-08-29 US gov't reveals drugs subject to Medicare price debate

TeleTrader 2023-08-01 Merck posts Q2 sales of $15B, rising 3%

TeleTrader 2023-06-06 WH defends Medicare over Merck lawsuit

TeleTrader 2023-06-06 Merck sues US gov't over drug price negotiations

UniCredit Call 140 MRK 15.05.2024/ DE000HD4VZ38 /

If you wish to receive reply to your feedback, please provide your email address.